Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment.

•HAIC provided benefit for HCC patients with microvascular invasion and selective multiple tumor after surgery.•HAIC is not suitable for every patients undergoing surgery.•Solitary HCC patients should not receive adjuvant HAIC, especially in non-HBV patients.